Operating profit before deduction of amortization: Pieris Pharmaceuticals, Inc. (PVLA)
Pieris Pharmaceuticals (PVLA) is currently undergoing an asset refresh phase at a low point in its clinical cycle. EBITDA tracking demonstrates the impact of this restructuring, with the current mark standing at 0.00. Growth potential is based on Anticalin patents for cancer treatment, while financial stability relies on royalties from strategic partners for the use of unique immune platforms.
Pieris Pharmaceuticals, Inc. (PVLA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Pieris Pharmaceuticals|PVLA - Long-Term Debt to Capital|Current Liabilities to Capital Pieris Pharma|PVLA - Company Debts|Debts to Book Capitalization Ratio Pieris Pharmaceuticals|PVLA - Company Long-Term Debts|Short-Term Debt Volume Pieris Pharmaceuticals|Immediate Liquidity pieris.com
- earnings and multiples data:
PVLA - Company Net Income|Expected Net Income Pieris Pharmaceuticals|PVLA - P/E Multiple|Market Cap to Projected Earnings pieris.com|PVLA - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Pieris Pharmaceuticals|PVLA - Operating profit before deduction of amortization|Earnings per share for the trailing year Pieris Pharmaceuticals|PVLA - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months pieris.com|PVLA - Earnings growth in current year|Expected earnings per share trend next year Pieris Pharmaceuticals
Analysis of all company metrics:Pieris Corp, PVLA
The prospects for Pieris Pharmaceuticals (PVLA) depend on portfolio restructuring and the search for new partners amid a clinical downturn. This metric measures the market valuation of the business's ability to generate real cash flow from its core operations. It is critical for investors to monitor the volatility of this indicator, as it signals risks or a shift in market expectations. Analyzing these fluctuations allows for an assessment of the company's resilience independent of the macroeconomic context. The operating profit summary on GURU.Markets visualizes this balance in real time.
Who Pieris Pharmaceuticals competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VERA|DNTH: Operating profit EBITDA|PHVS - Operating income before deduction of amortization|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Tourmaline Bio Inc TRML|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|Operating income before deduction of amortization upstreambio.com (UPB)|ZBIO - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Immunome Inc IMNM|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KalVista Corp - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Septerna Inc|savarapharma.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA RIGL|ANAB (AnaptysBio Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATXS (Astria Pharma)|Operating profit EBITDA enGene Corp ENGN|RAPT - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization JBIO (Aerovate Therapeutics Inc)|Aclaris Therapeutics, Inc. (ACRS) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Operating profit EBITDA|Operating profit EBITDA Cabaletta Bio Inc|Operating profit EBITDA VTYX|Operating profit before deduction of amortization theratech.com THTX|Operating profit EBITDA AVTX (Avalo Therapeutics)|Eledon Pharmaceuticals Inc. (ELDN) - Profit before interest, taxes and amortization|AGEN: Operating profit before deduction of amortization|CLYM - Operating profit EBITDA|ZURA (Zura Bio) - Operating profit before deduction of amortization|ATYR: Company profit before taxes, interest and amortization|ADAG (Adagene Inc) - Operating profit EBITDA|Ikena Oncology, Inc. (IMA) - Operating income before deduction of amortization|Operating profit EBITDA STTK|Operating profit before deduction of amortization equilliumbio.com EQ|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Operating profit EBITDA Immunic Therapeutics IMUX|ATRA - Profit before payment of interest, taxes and amortization|IFRX: Profit before payment of interest, taxes and amortization|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|ACET - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Celularity Inc|inmunebio.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit before deduction of amortization BRNS (Barinthus Biotherapeutics plc)|Profit before payment of interest, taxes and amortization KZR (Kezar Life Sciences Inc.)|Profit before payment of interest, taxes and amortization SAB Biotherapeutics, Inc SABS|Akari Therapeutics, Plc - Profit before payment of interest, taxes and amortization|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization EDSA (Edesa Biotech Inc)|IBIO (iBio Corp) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit EBITDA boltbio.com (BOLT)|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|Income before deduction of interest, taxes and amortization APVO|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI: Operating profit EBITDA|xortx.com (XRTX) - Operating profit EBITDA|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INDP|Operating income before deduction of amortization BiondVax Pharmaceuticals|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD - Operating profit before deduction of amortization|ALLK - Profit before payment of interest, taxes and amortization|HOOKIPA Pharma Inc. (HOOK) - Operating profit before deduction of amortization|IGMS (igmbio.com) - Operating profit before deduction of amortization|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit EBITDA THRD
